Publication | Closed Access

Effect of CYP2C19*2 and *17 Genetic Variants on Platelet Response to Clopidogrel and Prasugrel Maintenance Dose and Relation to Bleeding Complications

ThrombopoiesisThrombosisBleeding ComplicationsGenetic VariantsCardiovascular DiseasePlatelet ResponseMedicineBlood PlateletHematologyVascular BiologyPharmacotherapyBleeding DisorderPlatelet AntagonistPharmacologyAnticoagulant